Advertisement

Laser and Radiofrequency Ablation Procedures

  • Petros Tsamatropoulos
  • Roberto ValcaviEmail author
Chapter

Abstract

The term interventional thyroidology refers to minimally invasive ultrasound-guided techniques to treat diseases of the endocrine neck, i.e., diseases of thyroid and parathyroid glands. Laser ablation (LA) and radiofrequency ablation (RFA) are two of these procedures used to destroy thyroid nodules and tumors using hyperthermia without surgical removal. Indications of LA and RFA technique for the treatment of endocrine neck diseases include symptomatic benign cold thyroid nodules, symptomatic thyroid cysts, autonomously functioning thyroid nodules, and recurrent thyroid cancer. Both thermal techniques have also been used for the treatment of parathyroid adenomas, but with several drawbacks and are no longer recommended. The advantages of in situ tumor ablation are reduced costs, the possibility of performing procedures on outpatients, the possibility of treating patients who are poor candidates for surgery due to age or comorbidity, and the possibility of treating patients who refuse surgery. LA and RFA are performed by endocrinologists, interventional radiologists, and surgeons.

Keywords

Interventional thyroidology Radiofrequency ablation Laser ablation Thyroid nodule Thyroid ultrasound Hot nodule Thyroid cyst Spongiform nodule Parathyroid adenoma Thyroid cancer 

References

  1. 1.
    Bown SG. Phototherapy in tumors. World J Surg. 1983;7(6):700–9.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Nolsøe CP, Torp-Pedersen S, Burcharth F, Horn T, Pedersen S, Christensen NE, et al. Interstitial hyperthermia of colorectal liver metastases with a US-guided Nd-YAG laser with a diffuser tip: a pilot clinical study. Radiology. 1993;187(2):333–7.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Amin Z, Harries SA, Lees WR, Bown SG. Interstitial tumour photocoagulation. Endosc Surg Allied Technol. 1993;1(4):224–9.PubMedPubMedCentralGoogle Scholar
  4. 4.
    Germer CT, Roggan A, Ritz JP, Isbert C, Albrecht D, Müller G, et al. Optical properties of native and coagulated human liver tissue and liver metastases in the near infrared range. Lasers Surg Med. 1998;23(4):194–203.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Heisterkamp J, van Hillegersberg R, Ijzermans JN. Interstitial laser coagulation for hepatic tumours. Br J Surg. 1999;86(3):293–304.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Nikfarjam M, Muralidharan V, Malcontenti-Wilson C, Christophi C. Progressive microvascular injury in liver and colorectal liver metastases following laser induced focal hyperthermia therapy. Lasers Surg Med. 2005;37(1):64–73.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Ritz JP, Lehmann KS, Zurbuchen U, Knappe V, Schumann T, Buhr HJ, et al. Ex vivo and in vivo evaluation of laser-induced thermotherapy for nodular thyroid disease. Lasers Surg Med. 2009;41(7):479–86.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Piana S, Riganti F, Froio E, Andrioli M, Pacella CM, Valcavi R. Pathological findings of thyroid nodules after percutaneous laser ablation: a series of 22 cases with cyto-histological correlation. Endocr Pathol. 2012;23(2):94–100.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Ritz JP, Roggan A, Isbert C, Müller G, Buhr HJ, Germer CT. Optical properties of native and coagulated porcine liver tissue between 400 and 2400 nm. Lasers Surg Med. 2001;29(3):205–12.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Hegedus L. Therapy: a new nonsurgical therapy option for benign thyroid nodules? Nat Rev Endocrinol. 2009;5(9):476–8.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Baek JH, Lee JH, Valcavi R, Pacella CM, Rhim H, Na DG. Thermal ablation for benign thyroid nodules: radiofrequency and laser. Korean J Radiol. 2011;12(5):525–40.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Gharib H, Hegedüs L, Pacella CM, Baek JH, Papini E. Clinical review: nonsurgical, image-guided, minimally invasive therapy for thyroid nodules. J Clin Endocrinol Metab. 2013;98(10):3949–57.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1–133.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Hegedüs L, AACE/AME/ETA Task Force on Thyroid Nodules, et al. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract. 2010;16(Suppl 1):1–43.CrossRefGoogle Scholar
  15. 15.
    Gharib H, Papini E, Garber JR, Duick DS, Harrell RM, Hegedüs L. American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules – 2016 update. Endocr Pract. 2016;22(5):622–39.PubMedPubMedCentralGoogle Scholar
  16. 16.
    Pacella CM, Bizzarri G, Guglielmi R, Anelli V, Bianchini A, Crescenzi A, et al. Thyroid tissue: US-guided percutaneous interstitial laser ablation-a feasibility study. Radiology. 2000;217(3):673–7.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Døssing H, Bennedbaek FN, Karstrup S, Hegedüs L. Benign solitary solid cold thyroid nodules: US-guided interstitial laser photocoagulation—initial experience. Radiology. 2002;225(1):53–7.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Pacella CM, Bizzarri G, Spiezia S, Bianchini A, Guglielmi R, Crescenzi A, et al. Thyroid tissue: US-guided percutaneous laser thermal ablation. Radiology. 2004;232(1):272–80.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Papini E, Guglielmi R, Bizzarri G, Pacella CM. Ultrasound-guided laser thermal ablation for treatment of benign thyroid nodules. Endocr Pract. 2004;10(3):276–83.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Cakir B, Topaloglu O, Gul K, Agac T, Aydin C, Dirikoc A, et al. Effects of percutaneous laser ablation treatment in benign solitary thyroid nodules on nodule volume, thyroglobulin and anti-thyroglobulin levels, and cytopathology of nodule in 1 yr follow-up. J Endocrinol Investig. 2006;29(10):876–84.CrossRefGoogle Scholar
  21. 21.
    Amabile G, Rotondi M, De Chiara G, Silvestri A, Di Filippo B, Bellastella A, et al. Low-energy interstitial laser photocoagulation for treatment of nonfunctioning thyroid nodules: therapeutic outcome in relation to pretreatment and treatment parameters. Thyroid. 2006;16(8):749–55.CrossRefGoogle Scholar
  22. 22.
    Døssing H, Bennedbaek FN, Hegedüs L. Effect of ultrasound-guided interstitial laser photocoagulation on benign solitary solid cold thyroid nodules: one versus three treatments. Thyroid. 2006;16(8):763–8.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Valcavi R, Riganti F, Bertani A, Formisano D, Pacella CM. Percutaneous laser ablation of cold benign thyroid nodules. A three-year follow-up in 122 patients. Thyroid. 2010;20(11):1253–61.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Døssing H, Bennedbæk FN, Hegedüs L. Long-term outcome following interstitial laser photocoagulation of benign cold thyroid nodules. Eur J Endocrinol. 2011;165(1):123–8.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Amabile G, Rotondi M, Pirali B, Dionisio R, Agozzino L, Lanza M, et al. Interstitial laser photocoagulation for benign thyroid nodules: time to treat large nodules. Lasers Surg Med. 2011;43(8):797–803.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Gambelunghe G, Fede R, Bini V, Monacelli M, Avenia N, D’Ajello M, et al. Ultrasound-guided interstitial laser ablation for thyroid nodules is effective only at high total amounts of energy: results from a three-year pilot study. Surg Innov. 2013;20(4):345–50.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Achille G, Zizzi S, Di Stasio E, Grammatica A, Grammatica L. Ultrasound-guided percutaneous laser ablation in treating symptomatic solid benign thyroid nodules: our experience in 45 patients. Head Neck. 2016;38(5):677–82.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Pacella CM, Mauri G, Achille G, Barbaro D, Bizzarri G, De Feo P, et al. Outcomes and risk factors for complications of laser ablation for thyroid nodules: a Multicenter study on 1531 patients. J Clin Endocrinol Metab. 2015;100(10):3903–10.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Negro R, Salem TM, Greco G. Laser ablation is more effective for spongiform than solid thyroid nodules. A 4-year retrospective follow-up study. Int J Hyperth. 2016;32(7):822–8.CrossRefGoogle Scholar
  30. 30.
    Døssing H, Bennedbaek FN, Hegedüs L. Beneficial effect of combined aspiration and interstitial laser therapy in patients with benign cystic thyroid nodules: a pilot study. Br J Radiol. 2006;79(948):943–7.CrossRefGoogle Scholar
  31. 31.
    Døssing H, Bennedbæk FN, Hegedüs L. Interstitial laser photocoagulation (ILP) of benign cystic thyroid nodules—a prospective randomized trial. J Clin Endocrinol Metab. 2013;98(7):E1213–7.CrossRefGoogle Scholar
  32. 32.
    Døssing H, Bennedbaek FN, Hegedüs L. Ultrasound-guided interstitial laser photocoagulation of an autonomous thyroid nodule: the introduction of a novel alternative. Thyroid. 2003;13(9):885–8.CrossRefGoogle Scholar
  33. 33.
    Spiezia S, Vitale G, Di Somma C, Pio Assanti A, Ciccarelli A, Lombardi G, et al. Ultrasound-guided laser thermal ablation in the treatment of autonomous hyperfunctioning thyroid nodules and compressive nontoxic nodular goiter. Thyroid. 2003;13(10):941–7.CrossRefGoogle Scholar
  34. 34.
    Barbaro D, Orsini P, Lapi P, Pasquini C, Tuco A, Righini A, et al. Percutaneous laser ablation in the treatment of toxic and pretoxic nodular goiter. Endocr Pract. 2007;13(1):30–6.CrossRefGoogle Scholar
  35. 35.
    Cakir B, Gul K, Ugras S, Ersoy R, Topaloglu O, Agac T, et al. Percutaneous laser ablation of an autonomous thyroid nodule: effects on nodule size and histopathology of the nodule 2 years after the procedure. Thyroid. 2008;18(7):803–5.CrossRefGoogle Scholar
  36. 36.
    Rotondi M, Amabile G, Leporati P, Di Filippo B, Chiovato L. Repeated laser thermal ablation of a large functioning thyroid nodule restores euthyroidism and ameliorates constrictive symptoms. J Clin Endocrinol Metab. 2009;94(2):382–3.CrossRefGoogle Scholar
  37. 37.
    Chianelli M, Bizzarri G, Todino V, Misischi I, Bianchini A, Graziano F, et al. Laser ablation and 131-iodine: a 24-month pilot study of combined treatment for large toxic nodular goiter. J Clin Endocrinol Metab. 2014;99(7):E1283–6.CrossRefGoogle Scholar
  38. 38.
    Negro R, Greco G. Large multinodular toxic goiter: is surgery always necessary? Case Rep Endocrinol. 2016;2016:1320827.PubMedPubMedCentralGoogle Scholar
  39. 39.
    Døssing H, Bennedbaek FN, Hegedüs L. Effect of ultrasound-guided interstitial laser photocoagulation on benign solitary solid cold thyroid nodules – a randomised study. Eur J Endocrinol. 2005;152(3):341–5.CrossRefGoogle Scholar
  40. 40.
    Papini E, Guglielmi R, Bizzarri G, Graziano F, Bianchini A, Brufani C, et al. Treatment of benign cold thyroid nodules: a randomized clinical trial of percutaneous laser ablation versus levothyroxine therapy or follow-up. Thyroid. 2007;17(3):229–35.CrossRefGoogle Scholar
  41. 41.
    Døssing H, Bennedbaek FN, Bonnema SJ, Grupe P, Hegedüs L. Randomized prospective study comparing a single radioiodine dose and a single laser therapy session in autonomously functioning thyroid nodules. Eur J Endocrinol. 2007;157(1):95–100.CrossRefGoogle Scholar
  42. 42.
    Gambelunghe G, Fatone C, Ranchelli A, Fanelli C, Lucidi P, Cavaliere A, et al. A randomized controlled trial to evaluate the efficacy of ultrasound-guided laser photocoagulation for treatment of benign thyroid nodules. J Endocrinol Investig. 2006;29(9):RC23–6.CrossRefGoogle Scholar
  43. 43.
    Papini E, Rago T, Gambelunghe G, Valcavi R, Bizzarri G, Vitti P, et al. Long-term efficacy of ultrasound-guided laser ablation for benign solid thyroid nodules. Results of a three-year multicenter prospective randomized trial. J Clin Endocrinol Metab. 2014;99(10):3653–9.CrossRefGoogle Scholar
  44. 44.
    Cakir B, Gul K, Ersoy R, Topaloglu O, Korukluoglu B. Subcapsular hematoma complication during percutaneous laser ablation to a hypoactive benign solitary thyroid nodule. Thyroid. 2008;18(8):917–8.CrossRefGoogle Scholar
  45. 45.
    Di Rienzo G, Surrente C, Lopez C, Quercia R. Tracheal laceration after laser ablation of nodular goitre. Interact Cardiovasc Thorac Surg. 2012;14(1):115–6.CrossRefGoogle Scholar
  46. 46.
    Valcavi R, Stecconi Bortolani G, Riganti F, Pacella C. Thyroid spongiform nodules are the best candidates for percutaneous laser ablation. A 5 year follow-up study in 72 patients. Presented at 15th International & 14th European Congress of Endocrinology, 2012, Florence, Italy. Endocrine Abstracts 29 OC2.5.Google Scholar
  47. 47.
    Valcavi R, Frasoldati A. Ultrasound-guided percutaneous ethanol injection therapy in thyroid cystic nodules. Endocr Pract. 2004;10(3):269–75.CrossRefGoogle Scholar
  48. 48.
    Durante C, Montesano T, Torlontano M, Attard M, Monzani F, Tumino S, et al. Papillary thyroid cancer: time course of recurrences during post surgery surveillance. Clin Endocrinol Metab. 2013;98(2):636–42.CrossRefGoogle Scholar
  49. 49.
    Samaan NA, Schultz PN, Hickey RC, Goepfert H, Haynie TP, Johnston DA, et al. The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patients. J Clin Endocrinol Metab. 1992;75(3):714–20.PubMedGoogle Scholar
  50. 50.
    Papini E, Bizzarri G, Bianchini A, Valle D, Misischi I, Guglielmi R, et al. Percutaneous ultrasound-guided laser ablation is effective for treating selected nodal metastases in papillary thyroid cancer. J Clin Endocrinol Metab. 2013;98(1):E92–7.CrossRefGoogle Scholar
  51. 51.
    Mauri G, Cova L, Tondolo T, Ierace T, Baroli A, Di Mauro E, et al. Percutaneous laser ablation of metastatic lymph nodes in the neck from papillary thyroid carcinoma: preliminary results. J Clin Endocrinol Metab. 2013;98(7):E1203–7.CrossRefGoogle Scholar
  52. 52.
    Zhou W, Zhang L, Zhan W, Jiang S, Zhu Y, Xu S. Percutaneous laser ablation for treatment of locally recurrent papillary thyroid carcinoma <15 mm. Clin Radiol. 2016;71(12):1233–9.  https://doi.org/10.1016/j.crad.2016.07.010.CrossRefPubMedGoogle Scholar
  53. 53.
    Mauri G, Cova L, Ierace T, Baroli A, Di Mauro E, Pacella CM, et al. Treatment of metastatic lymph nodes in the neck from papillary thyroid carcinoma with percutaneous laser ablation. Cardiovasc Intervent Radiol. 2016;39(7):1023–30.  https://doi.org/10.1007/s00270-016-1313-6.CrossRefPubMedGoogle Scholar
  54. 54.
    Valcavi R, Piana S, Bortolan GS, Lai R, Barbieri V, Negro R. Ultrasound-guided percutaneous laser ablation of papillary thyroid microcarcinoma: a feasibility study on three cases with pathological and immunohistochemical evaluation. Thyroid. 2013;23(12):1578–82.CrossRefGoogle Scholar
  55. 55.
    Baloch ZW, LiVolsi VA, Asa SL, Rosai J, Merino MJ, Randolph G, et al. Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute thyroid fine-needle aspiration state of the science conference. Diagn Cytopathol. 2008;36(6):425–37.CrossRefGoogle Scholar
  56. 56.
    Andrioli M, Riganti F, Pacella CM, Valcavi R. Long-term effectiveness of ultrasound-guided laser ablation of hyperfunctioning parathyroid adenomas: present and future perspectives. AJR Am J Roentgenol. 2012;199(5):1164–8.CrossRefGoogle Scholar
  57. 57.
    Ha EJ, Baek JH, Lee JH. The efficacy and complications of radiofrequency ablation of thyroid nodules. Curr Opin Endocrinol Diabetes Obes. 2011;18(5):310–4.CrossRefGoogle Scholar
  58. 58.
    Na DG, Lee JH, Jung SL, Kim JH, Sung JY, Shin JH, Korean Society of Thyroid Radiology (KSThR); Korean Society of Radiology, et al. Radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: consensus statement and recommendations. Korean J Radiol. 2012;13(2):117–25.CrossRefPubMedPubMedCentralGoogle Scholar
  59. 59.
    Garberoglio R, Aliberti C, Appetecchia M, Attard M, Boccuzzi G, Boraso F, et al. Radiofrequency ablation for thyroid nodules: which indications? The first Italian opinion statement. J Ultrasound. 2015;18(4):423–30.CrossRefPubMedPubMedCentralGoogle Scholar
  60. 60.
    Korkusuz Y, Erbelding C, Kohlhase K, Luboldt W, Happel C, Grünwald F. Bipolar radiofrequency ablation of benign symptomatic thyroid nodules: initial experience. Rofo. 2016;188(7):671–5.PubMedPubMedCentralGoogle Scholar
  61. 61.
    Li XL, Xu HX, Lu F, Yue WW, Sun LP, Bo XW, et al. Treatment efficacy and safety of ultrasound-guided percutaneous bipolar radiofrequency ablation for benign thyroid nodules. Br J Radiol. 2016;89(1059):2015085.  https://doi.org/10.1259/bjr.20150858.CrossRefGoogle Scholar
  62. 62.
    Kohlhase KD, Korkusuz Y, Gröner D, Erbelding C, Happel C, Luboldt W, et al. Bipolar radiofrequency ablation of benign thyroid nodules using a multiple overlapping shot technique in a 3-month follow-up. Int J Hyperth. 2016;32(5):511–6.  https://doi.org/10.3109/02656736.2016.1149234.CrossRefGoogle Scholar
  63. 63.
    Spiezia S, Garberoglio R, Di Somma C, Deandrea M, Basso E, Limone PP, et al. Efficacy and safety of radiofrequency thermal ablation in the treatment of thyroid nodules with pressure symptoms in elderly patients. J Am Geriatr Soc. 2007;55(9):1478–9.CrossRefPubMedPubMedCentralGoogle Scholar
  64. 64.
    Deandrea M, Limone P, Basso E, Mormile A, Ragazzoni F, Gamarra E, et al. US-guided percutaneous radiofrequency thermal ablation for the treatment of solid benign hyperfunctioning or compressive thyroid nodules. Ultrasound Med Biol. 2008;34(5):784–91.CrossRefPubMedPubMedCentralGoogle Scholar
  65. 65.
    Spiezia S, Garberoglio R, Milone F, Ramundo V, Caiazzo C, Assanti AP, et al. Thyroid nodules and related symptoms are stably controlled two years after radiofrequency thermal ablation. Thyroid. 2009;19(3):219–25.CrossRefPubMedPubMedCentralGoogle Scholar
  66. 66.
    Baek JH, Moon WJ, Kim YS, Lee JH, Lee D. Radiofrequency ablation for the treatment of autonomously functioning thyroid nodules. World J Surg. 2009;33(9):1971–7.CrossRefPubMedPubMedCentralGoogle Scholar
  67. 67.
    Shin JH, Baek JH, Ha EJ, Lee JH. Radiofrequency ablation of thyroid nodules: basic principles and clinical application. Int J Endocrinol. 2012;2012:919650.CrossRefPubMedPubMedCentralGoogle Scholar
  68. 68.
    Valcavi R, Tsamatropoulos P. Health-related quality of life after percutaneous radiofrequency ablation of cold, solid, benign thyroid nodules: a 2-year follow-up study in 40 patients. Endocr Pract. 2015;21(8):887–96.CrossRefGoogle Scholar
  69. 69.
    Deandrea M, Sung JY, Limone P, Mormile A, Garino F, Ragazzoni F, et al. Efficacy and safety of radiofrequency ablation versus observation for nonfunctioning benign thyroid nodules: a randomized controlled international collaborative trial. Thyroid. 2015;25(8):890–6.CrossRefGoogle Scholar
  70. 70.
    Baek JH, Lee JH, Sung JY, Bae JI, Kim KT, Sim J, et al. Korean Society of Thyroid Radiology. Complications encountered in the treatment of benign thyroid nodules with US-guided radiofrequency ablation: a multicenter study. Radiology. 2012;262(1):335–42.CrossRefPubMedPubMedCentralGoogle Scholar
  71. 71.
    Ha EJ, Baek JH, Lee JH. Ultrasonography-based thyroidal and perithyroidal anatomy and its clinical significance. Korean J Radiol. 2015;16(4):749–66.CrossRefPubMedPubMedCentralGoogle Scholar
  72. 72.
    Ha EJ, Baek JH, Lee JH, Kim JK, Shong YK. Clinical significance of vagus nerve variation in radiofrequency ablation of thyroid nodules. Eur Radiol. 2011;21(10):2151–7.CrossRefPubMedPubMedCentralGoogle Scholar
  73. 73.
    Shin JH, Jung SL, Baek JH, Kim JH. Rupture of benign thyroid tumors after radio-frequency ablation. AJNR Am J Neuroradiol. 2011;32(11):2165–9.CrossRefPubMedPubMedCentralGoogle Scholar
  74. 74.
    Chehade JM, Silverberg AB, Kim J, Case C, Mooradian AD. Role of repeated fine-needle aspiration of thyroid nodules with benign cytologic features. Endocr Pract. 2001;7(4):237–43.CrossRefPubMedPubMedCentralGoogle Scholar
  75. 75.
    Illouz F, Rodien P, Saint-André JP, Triau S, Laboureau-Soares S, Dubois S, et al. Usefulness of repeated fine-needle cytology in the follow-up of non-operated thyroid nodules. Eur J Endocrinol. 2007;156(3):303–8.CrossRefPubMedPubMedCentralGoogle Scholar
  76. 76.
    Kwak JY, Koo H, Youk JH, Kim MJ, Moon HJ, Son EJ, et al. Value of US correlation of a thyroid nodule with initially benign cytologic results. Radiology. 2010;254(1):292–300.CrossRefPubMedPubMedCentralGoogle Scholar
  77. 77.
    Piana S, Frasoldati A, Ferrari M, Valcavi R, Froio E, Barbieri V, et al. Is a five-category reporting scheme for thyroid fine needle aspiration cytology accurate? Experience of over 18,000 FNAs reported at the same institution during 1998–2007. Cytopathology. 2011;22(3):164–73.CrossRefPubMedPubMedCentralGoogle Scholar
  78. 78.
    Kim YS, Rhim H, Tae K, Park DW, Kim ST. Radiofrequency ablation of benign cold thyroid nodules: initial clinical experience. Thyroid. 2006;16(4):361–7.CrossRefPubMedPubMedCentralGoogle Scholar
  79. 79.
    Fuller CW, Nguyen SA, Lohia S, Gillespie MB. Radiofrequency ablation for treatment of benign thyroid nodules: systematic review. Laryngoscope. 2014;124(1):346–53.CrossRefPubMedPubMedCentralGoogle Scholar
  80. 80.
    Bandeira-Echtler E, Bergerhoff K, Richter B. Levothyroxine or minimally invasive therapies for benign thyroid nodules. Cochrane Database Syst Rev. 2014;6:CD004098.Google Scholar
  81. 81.
    Chen F, Tian G, Kong D, Zhong L, Jiang T. Radiofrequency ablation for treatment of benign thyroid nodules: a PRISMA-compliant systematic review and meta-analysis of outcomes. Medicine (Baltimore). 2016;95(34):e4659.CrossRefGoogle Scholar
  82. 82.
    Bernardi S, Dobrinja C, Fabris B, Bazzocchi G, Sabato N, Ulcigrai V, et al. Radiofrequency ablation compared to surgery for the treatment of benign thyroid nodules. Int J Endocrinol. 2014;2014:934595.CrossRefPubMedPubMedCentralGoogle Scholar
  83. 83.
    Che Y, Jin S, Shi C, Wang L, Zhang X, Li Y, Baek JH. Treatment of benign thyroid nodules: comparison of surgery with radiofrequency ablation. AJNR Am J Neuroradiol. 2015;36(7):1321–5.CrossRefPubMedPubMedCentralGoogle Scholar
  84. 84.
    Baek JH, Kim YS, Lee D, Huh JY, Lee JH. Benign predominantly solid thyroid nodules: prospective study of efficacy of sonographically guided radiofrequency ablation versus control condition. AJR Am J Roentgenol. 2010;194(4):1137–42.CrossRefPubMedPubMedCentralGoogle Scholar
  85. 85.
    Faggiano A, Ramundo V, Assanti AP, Fonderico F, Macchia PE, Misso C, et al. Thyroid nodules treated with percutaneous radiofrequency thermal ablation: a comparative study. J Clin Endocrinol Metab. 2012;97(12):4439–45.CrossRefPubMedPubMedCentralGoogle Scholar
  86. 86.
    Wong KP, Lang BH. Use of radiofrequency ablation in benign thyroid nodules: a literature review and updates. Int J Endocrinol. 2013;2013:428363.CrossRefPubMedPubMedCentralGoogle Scholar
  87. 87.
    Turtulici G, Orlandi D, Corazza A, Sartoris R, Derchi LE, Silvestri E, et al. Percutaneous radiofrequency ablation of benign thyroid nodules assisted by a virtual needle tracking system. Ultrasound Med Biol. 2014;40(7):1447–52.CrossRefPubMedPubMedCentralGoogle Scholar
  88. 88.
    Cesareo R, Pasqualini V, Simeoni C, Sacchi M, Saralli E, Campagna G, et al. Prospective study of effectiveness of ultrasound-guided radiofrequency ablation versus control group in patients affected by benign thyroid nodules. J Clin Endocrinol Metab. 2015;100(2):460–6.CrossRefPubMedPubMedCentralGoogle Scholar
  89. 89.
    Ugurlu MU, Uprak K, Akpinar IN, Attaallah W, Yegen C, Gulluoglu BM. Radiofrequency ablation of benign symptomatic thyroid nodules: prospective safety and efficacy study. World J Surg. 2015;39(4):961–8.CrossRefPubMedPubMedCentralGoogle Scholar
  90. 90.
    De Bernardi IC, Floridi C, Muollo A, Giacchero R, Dionigi GL, Reginelli A, et al. Vascular and interventional radiology radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: literature review. Radiol Med. 2014;119(7):512–20.CrossRefPubMedPubMedCentralGoogle Scholar
  91. 91.
    Jeong WK, Baek JH, Rhim H, Kim YS, Kwak MS, Jeong HJ, et al. Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients. Eur Radiol. 2008;18(6):1244–50.CrossRefPubMedPubMedCentralGoogle Scholar
  92. 92.
    Huh JY, Baek JH, Choi H, Kim JK, Lee JH. Symptomatic benign thyroid nodules: efficacy of additional radiofrequency ablation treatment session-prospective randomized study. Radiology. 2012;263(3):909–16.CrossRefPubMedPubMedCentralGoogle Scholar
  93. 93.
    Lim HK, Lee JH, Ha EJ, Sung JY, Kim JK, Baek JH. Radiofrequency ablation of benign non-functioning thyroid nodules: 4-year follow-up results for 111 patients. Eur Radiol. 2013;23(4):1044–9.CrossRefPubMedPubMedCentralGoogle Scholar
  94. 94.
    Dobrinja C, Bernardi S, Fabris B, Eramo R, Makovac P, Bazzocchi G, et al. Surgical and pathological changes after radiofrequency ablation of thyroid nodules. Int J Endocrinol. 2015;2015:576576.CrossRefPubMedPubMedCentralGoogle Scholar
  95. 95.
    Ha EJ, Baek JH, Lee JH, Sung JY, Lee D, Kim JK, et al. Radiofrequency ablation of benign thyroid nodules does not affect thyroid function in patients with previous lobectomy. Thyroid. 2013;23(3):289–93.CrossRefPubMedPubMedCentralGoogle Scholar
  96. 96.
    Ji Hong M, Baek JH, Choi YJ, Lee JH, Lim HK, Shong YK, et al. Radiofrequency ablation is a thyroid function-preserving treatment for patients with bilateral benign thyroid nodules. J Vasc Interv Radiol. 2015;26(1):55–61.CrossRefPubMedPubMedCentralGoogle Scholar
  97. 97.
    Andrioli M, Valcavi R. The peculiar ultrasonographic and elastographic features of thyroid nodules after treatment with laser or radiofrequency: similarities and differences. Endocrine. 2014;47(3):967–8.CrossRefPubMedPubMedCentralGoogle Scholar
  98. 98.
    Sung JY, Kim YS, Choi H, Lee JH, Baek JH. Optimum first-line treatment technique for benign cystic thyroid nodules: ethanol ablation or radiofrequency ablation? AJR Am J Roentgenol. 2011;196(2):W210–4.CrossRefPubMedPubMedCentralGoogle Scholar
  99. 99.
    Sung JY, Baek JH, Kim KS, Lee D, Yoo H, Kim JK, Park SH. Single-session treatment of benign cystic thyroid nodules with ethanol versus radiofrequency ablation: a prospective randomized study. Radiology. 2013;269(1):293–300.CrossRefPubMedPubMedCentralGoogle Scholar
  100. 100.
    Baek JH, Ha EJ, Choi YJ, Sung JY, Kim JK, Shong YK. Radiofrequency versus ethanol ablation for treating predominantly cystic thyroid nodules: a randomized clinical trial. Korean J Radiol. 2015;16(6):1332–40.CrossRefPubMedPubMedCentralGoogle Scholar
  101. 101.
    Lee JH, Kim YS, Lee D, Choi H, Yoo H, Baek JH. Radiofrequency ablation (RFA) of benign thyroid nodules in patients with incompletely resolved clinical problems after ethanol ablation (EA). World J Surg. 2010;34(7):1488–93.CrossRefGoogle Scholar
  102. 102.
    Jang SW, Baek JH, Kim JK, Sung JY, Choi H, Lim HK, et al. How to manage the patients with unsatisfactory results after ethanol ablation for thyroid nodules: role of radiofrequency ablation. Eur J Radiol. 2012;81(5):905–10.CrossRefGoogle Scholar
  103. 103.
    Baek JH, Jeong HJ, Kim YS, Kwak MS, Lee D. Radiofrequency ablation for an autonomously functioning thyroid nodule. Thyroid. 2008;18(6):675–6.CrossRefGoogle Scholar
  104. 104.
    Sung JY, Baek JH, Jung SL, Kim JH, Kim KS, Lee D, et al. Radiofrequency ablation for autonomously functioning thyroid nodules: a multicenter study. Thyroid. 2015;25(1):112–7.CrossRefPubMedPubMedCentralGoogle Scholar
  105. 105.
    Dupuy DE, Monchik JM, Decrea C, Pisharodi L. Radiofrequency ablation of regional recurrence from well-differentiated thyroid malignancy. Surgery. 2001;130(6):971–7.CrossRefGoogle Scholar
  106. 106.
    Monchik JM, Donatini G, Iannuccilli J, Dupuy DE. Radiofrequency ablation and percutaneous ethanol injection treatment for recurrent local and distant well-differentiated thyroid carcinoma. Ann Surg. 2006;244(2):296–304.CrossRefPubMedPubMedCentralGoogle Scholar
  107. 107.
    Baek JH, Kim YS, Sung JY, Choi H, Lee JH. Locoregional control of metastatic well-differentiated thyroid cancer by ultrasound-guided radiofrequency ablation. AJR Am J Roentgenol. 2011;197(2):W331–6.CrossRefGoogle Scholar
  108. 108.
    Park KW, Shin JH, Han BK, Ko EY, Chung JH. Inoperable symptomatic recurrent thyroid cancers: preliminary result of radiofrequency ablation. Ann Surg Oncol. 2011;18(9):2564–8.CrossRefGoogle Scholar
  109. 109.
    Shin JE, Baek JH, Lee JH. Radiofrequency and ethanol ablation for the treatment of recurrent thyroid cancers: current status and challenges. Curr Opin Oncol. 2013;25(1):14–9.CrossRefGoogle Scholar
  110. 110.
    Lee SJ, Jung SL, Kim BS, Ahn KJ, Choi HS, Lim DJ, et al. Radiofrequency ablation to treat loco-regional recurrence of well-differentiated thyroid carcinoma. Korean J Radiol. 2014;15(6):817–26.CrossRefPubMedPubMedCentralGoogle Scholar
  111. 111.
    Wang L, Ge M, Xu D, Chen L, Qian C, Shi K, et al. Ultrasonography-guided percutaneous radiofrequency ablation for cervical lymph node metastasis from thyroid carcinoma. J Cancer Res Ther. 2014;10(Suppl):C144–9.PubMedPubMedCentralGoogle Scholar
  112. 112.
    Lim HK, Baek JH, Lee JH, Kim WB, Kim TY, Shong YK, et al. Efficacy and safety of radiofrequency ablation for treating locoregional recurrence from papillary thyroid cancer. Eur Radiol. 2015;25(1):163–70.CrossRefGoogle Scholar
  113. 113.
    Kim JH, Yoo WS, Park YJ, Park do J, Yun TJ, Choi SH, et al. Efficacy and safety of radiofrequency ablation for treatment of locally recurrent thyroid cancers smaller than 2 cm. Radiology. 2015;276(3):909–18.CrossRefPubMedPubMedCentralGoogle Scholar
  114. 114.
    Kim HS, Choi BH, Park JR, Hahm JR, Jung JH, Kim SK, et al. Delayed surgery for parathyroid adenoma misdiagnosed as a thyroid nodule and treated with radiofrequency ablation. Endocrinol Metab (Seoul). 2013;28(3):231–5.CrossRefGoogle Scholar
  115. 115.
    Xu SY, Wang Y, Xie Q, Wu HY. Percutaneous sonography guided radiofrequency ablation in the management of parathyroid adenoma. Singap Med J. 2013;54(7):e137–40.CrossRefGoogle Scholar
  116. 116.
    Kim BS, Eom TI, Kang KH, Park SJ. Radiofrequency ablation of parathyroid adenoma in primary hyperparathyroidism. J Med Ultrason (2001). 2014;41(2):239–43.CrossRefGoogle Scholar
  117. 117.
    Carrafiello G, Laganà D, Mangini M, Dionigi G, Rovera F, Carcano G, et al. Treatment of secondary hyperparathyroidism with ultrasonographically guided percutaneous radiofrequency thermoablation. Surg Laparosc Endosc Percutan Tech. 2006;16(2):112–6.CrossRefPubMedPubMedCentralGoogle Scholar
  118. 118.
    Lupo MA. Radiofrequency ablation for benign thyroid nodules – a look towards the future of interventional thyroidology. Endocr Pract. 2015;21(8):972–4.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.Endocrinology Unit, Centro PalmerReggio EmiliaItaly

Personalised recommendations